The Birth of A Drug
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Michael Greenberg talks to Katie MacFarlane, CEO and President of Xintria Pharmaceutical Corporation about how ideas become pharmaceuticals.
Overview
Dr. Michael Greenberg talks to Katie MacFarlane, CEO and President of Xintria Pharmaceutical Corporation about how ideas become pharmaceuticals.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Pulmonary Hypertension Management: Practice Trends and Updates
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?